Accordingly, high Cav1 expression is a negative prognostic factor for overall and disease-free survival in patients with various tumor types, including breast [31], esophagus [32], pancreas [33], kidney [34], and prostate tumors [35], meningioma [36] and oligodendroglioma [37]. This evidence concerns the gene CAV1 and neoplasm.